ArticleFrontiers in cardiovascular medicine2025
Construction of a risk prediction model for postoperative atrial fibrillation in lung cancer patients based on multi-dimensional feature fusion and ensemble learning.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Artificial intelligence in thoracic surgery: a narrative review of clinical advances and applications in 2025.Journal of thoracic disease · 2026Review
- Development and validation of a clinical prediction model for postoperative atrial fibrillation after lung cancer surgery: a machine-learning-based study.Frontiers in surgery · 2026Article
- Risk factors for atrial fibrillation after lung cancer surgery: a meta-analysis.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Surgery remains a cornerstone in lung cancer treatment, yet a subset of patients face high risks of recurrence or mortality postoperatively. Poor prognosis significantly shortens survival time, underscoring an urgent clinical need to accurately identify high-risk individuals. To address this, numerous studies have focused on constructing risk prediction models that integrate multi-dimensional data (clinical, pathological, and emerging biomarkers) to quantify postoperative adverse event probabilities, guiding personalized adjuvant therapy and enhancing follow-up management. To investigate risk factors for postoperative atrial fibrillation (POAF) in lung cancer patients and develop/validate a predictive model based on multi-dimensional feature fusion and ensemble learning. Methods: This retrospective cohort study analyzed 369 lung cancer patients undergoing surgical resection at Xinjiang Medical University Affiliated Tumor Hospital (2019-2024). Univariate analysis screened potential risk factors, followed by multivariable logistic regression to confirm independent predictors. Nine machine learning algorithms were employed to build predictive models, among which the top three performers were selected for ensemble modeling via weighted averaging, resulting in the final risk prediction model. Results: Multivariate analysis revealed three independent predictors of POAF: cardiac insufficiency (OR = 64.55, 95% CI: 2.41-1727.70), ventricular rate (OR = 1.17, 95% CI: 1.1-1.25), and elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP, OR = 1.005, 95% CI: 1-1.009). The Support Vector Machine (SVM), Random Forest (RF), and Gradient Boosting Machine (GBM) demonstrated the highest accuracy (ACC = 0.9041, 0.9178, and 0.9178, respectively). The ensemble model srg-LCPOAF further improved ACC to 0.9452, significantly outperforming individual algorithms. Discussion: This study is the first to integrate cardiopulmonary function, biomarkers, and surgical parameters into an ensemble model (srg-LCPOAF), providing evidence-based support for early intervention in high-risk POAF patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.